Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?
Wani
Mushtaq
M
Department of Stroke Medicine, Morriston Hospital, Morriston, Swansea SA6 6NL. mushtaq.wani@swansea-tr.wales.nhs.uk
Nga
Emma
E
Navaratnasingham
Ranjini
R
D000925:Anticoagulants; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000000981:diagnostic imaging; D000075202:Contraindications; D003657:Decision Making; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors